TTK-567(SYRNEIAYL) epitope peptide was also used to elicit cytotoxic T lymphocytes to establish cancer vaccines in lung, esophageal and advanced biliary tract cancers [28, 29]. This evidence concerns the gene TTK and biliary tract neoplasm.